Michael Cartwright
Impact in
-
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- Immune responses and vaccinations
- Immune cells in cancer
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Immunotherapy and Immune Responses 1
- Co-authors
- Mark J. Cameron (8 shared papers)Khader Ghneim (1 shared paper)Janko Nikolich‐Žugich (1 shared paper)Byung Park (1 shared paper)Julien van Grevenynghe (1 shared paper)John Hiscott (1 shared paper)Justin M. Richner (1 shared paper)Elias K. Haddad (1 shared paper)
- Journals
- PLoS Pathogens (1 paper)Frontiers in Immunology (1 paper)Journal of Investigative Dermatology (1 paper)The Journal of Infectious Diseases (1 paper)Biology (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
Michael Cartwright
7 papers receiving 200 citations
Peers
Comparison fields: 5 of 61
- Immunology 92
- Infectious Diseases 52
- Neurology 21
- Biological Psychiatry 6
- Neurology 21
Countries citing papers authored by Michael Cartwright
This map shows the geographic impact of Michael Cartwright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Cartwright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Cartwright more than expected).
Fields of papers citing papers by Michael Cartwright
This network shows the impact of papers produced by Michael Cartwright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Cartwright. The network helps show where Michael Cartwright may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Cartwright, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 134 | |
| 2 | 2020 | 28 | |
| 3 | 2020 | 21 | |
| 4 | 2021 | 10 | |
| 5 | 2020 | 6 | |
| 6 | 2019 | 1 | |
| 7 | 2022 | 1 | |
| 8 | 2024 | 0 |
About Michael Cartwright
Michael Cartwright is a scholar working on Immunology, Molecular Biology, Infectious Diseases, Surgery and Genetics, having authored 8 papers that have together received 201 indexed citations. Recurring topics across this work include HIV Research and Treatment (1 paper), Mesenchymal stem cell research (1 paper), Cytokine Signaling Pathways and Interactions (1 paper), MicroRNA in disease regulation (1 paper), Neuroinflammation and Neurodegeneration Mechanisms (1 paper), HIV-related health complications and treatments (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Immunology (92 citations), Infectious Diseases (52 citations), Neurology (21 citations), Biological Psychiatry (6 citations) and Neurology (21 citations). Michael Cartwright has collaborated with scholars based in United States and Canada. Frequent co-authors include Mark J. Cameron, Khader Ghneim, Janko Nikolich‐Žugich, Byung Park, Julien van Grevenynghe, John Hiscott, Justin M. Richner, Elias K. Haddad, David Olagnier and Talibah Metcalf. Their work appears in journals such as PLoS Pathogens, Frontiers in Immunology, Journal of Investigative Dermatology, The Journal of Infectious Diseases and Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.